CN111214549A - Nasal cavity nursing spray and preparation method thereof - Google Patents
Nasal cavity nursing spray and preparation method thereof Download PDFInfo
- Publication number
- CN111214549A CN111214549A CN202010163052.6A CN202010163052A CN111214549A CN 111214549 A CN111214549 A CN 111214549A CN 202010163052 A CN202010163052 A CN 202010163052A CN 111214549 A CN111214549 A CN 111214549A
- Authority
- CN
- China
- Prior art keywords
- parts
- solution
- nasal
- leaf
- nasal cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a nasal cavity nursing spray which is prepared from the following raw materials in parts by weight: 6-8 parts of centipeda minima, 3-5 parts of eucalyptus leaf extract, 2-4 parts of bay leaf extract, 3-5 parts of sandalwood extract, 4-6 parts of magnolia flower, 8-12 parts of menthol, 5-7 parts of plant cellulose, 1-3 parts of radix scutellariae, 6-8 parts of radix sophorae flavescentis, 5-7 parts of agastache rugosus and 1-3 parts of isotonic regulator. The invention not only can inhibit bacteria and diminish inflammation, but also can keep the inner surface of the nasal cavity moist for a long time, is beneficial to human health, has simple preparation process, no pollution and energy conservation, and is suitable for industrial implementation.
Description
Technical Field
The invention relates to the technical field of nasal cavity sprays, in particular to a nasal cavity nursing spray and a preparation method thereof.
Background
Rhinitis, an inflammatory disease of the nasal cavity, is inflammation of the mucous membrane of the nasal cavity caused by viruses, bacteria, allergens, various physicochemical factors and certain systemic diseases. The main pathological changes of rhinitis are congestion, swelling, exudation, hyperplasia, atrophy or necrosis of the nasal mucosa. Clinical symptoms include nasal obstruction, nasal discharge, hyposmia, headache, dizziness, etc. In addition, rhinitis, an inflammatory disease of the nasal cavity, refers to inflammation of the nasal mucosa and submucosal tissues, which is variously represented. Inflammation of nasal mucosa is generally caused by virus, bacteria, fungi, allergens, various physicochemical factors and systemic lesions. The rhinitis can be divided into a plurality of types according to different division angles, and from the pathological changes of nasal mucosa, the rhinitis comprises chronic simple rhinitis, chronic hypertrophic rhinitis, caseous rhinitis, atrophic rhinitis and the like, and from the aspects of urgency and slowness of onset and length of disease course, the rhinitis can be divided into acute rhinitis and chronic rhinitis. Allergic rhinitis (that is, allergic rhinitis) and rhinitis medicamentosa are the causes of the disease. However, whatever the cause of rhinitis, the main pathological changes are congestion, swelling and exudation of nasal mucosa; hyperplasia, atrophy, or necrosis, etc., wherein viral infection is the primary cause, and secondary bacterial infection is the basis of viral infection, and more than 100 viruses are known to cause the disease, the most common rhinovirus, coronavirus, coxsackie virus, and myxovirus and paramyxovirus, etc. Viral transmission is mainly from breathing to inhalation, and people usually use oral drugs or drug sprays to treat rhinitis, and also use nasal sprays to clean nasal cavities to relieve part of symptoms.
The existing nasal cavity spray is mainly used for sterilization and disinfection, and mainly comprises physiological saline, bactericides such as aspirin, ibuprofen, chlorpheniramine and other antibiotic medicines are added, although the nasal cavity cleaning solution can effectively kill most germs and has a certain sterilization and disinfection effect on nasal cavities, the side effect and the medication hazard degree to human bodies are increased by neglecting the use of medicines and antibiotic medicines for cleaning or sterilizing the nasal cavities, and most products in the market have single effect, the maintenance time for flushing the nasal cavities is short when the nasal cavities are used, some patients with dry, itchy and astringent nose often just spray the nasal cavities soon, the nose recovers the dry and itchy state again, and the use frequency of individual patients is increased due to the need of working or other aspects, so that inconvenience is brought to life, the nasal cavity bearing pressure is increased, and the nasal cavity patients can achieve the expected effect when the products are not used, have to be used continuously, which causes a lot of unnecessary troubles.
Disclosure of Invention
Aiming at the defects, the invention aims to provide a nasal cavity nursing spray and a preparation method thereof, which can inhibit bacteria and diminish inflammation, can keep the inner surface of a nasal cavity moist for a long time, are beneficial to human health, have simple preparation process, are free from pollution, save energy and are suitable for industrial implementation.
The invention is realized by the following technical scheme:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 6-8 parts of centipeda minima, 3-5 parts of eucalyptus leaf extract, 2-4 parts of bay leaf extract, 3-5 parts of sandalwood extract, 4-6 parts of magnolia flower, 8-12 parts of menthol, 5-7 parts of plant cellulose, 1-3 parts of radix scutellariae, 6-8 parts of radix sophorae flavescentis, 5-7 parts of agastache rugosus and 1-3 parts of isotonic regulator.
As an improvement of the technical proposal, the plant cellulose is prepared by smashing wheat bran and inorganic acid into pulp to prepare α -cellulose, then processing the α -cellulose to partially depolymerize the cellulose, and then removing non-crystalline parts and purifying the α -cellulose.
As an improvement of the above technical scheme, the eucalyptus leaf extract, the laurel leaf extract and the sandalwood extract are water saturated solutions prepared by respectively extracting fresh eucalyptus leaves, laurel leaves and sandalwood leaves by a distillation extraction method.
As an improvement of the technical scheme, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
As an improvement of the technical proposal, the solution obtained is irradiated by an ultraviolet light source to kill the microorganisms in the solution.
The invention has the beneficial effects that:
according to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better. In addition, the centipeda minima can treat stuffy nose and obstruction, nasosinusitis and watery nasal discharge, the menthol is used as an irritant in medicine and acts on skin or mucous membrane to achieve the effects of cooling and relieving itching, the magnolia flower can treat acute and chronic rhinitis, allergic rhinitis, hypertrophic rhinitis, nasosinusitis, paranasal sinusitis and the like, and the centipeda minima has the advantages of outstanding curative effect, high cure rate, simplicity, low cost and easiness in clinical popularization by matching with other medicinal auxiliary materials.
Detailed Description
Example 1:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 7 parts of centipeda minima, 4 parts of eucalyptus leaf extract, 3 parts of bay leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 10 parts of menthol, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of agastache rugosus and 2 parts of an isoosmotic adjusting agent.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
According to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better. In addition, the centipeda minima can treat stuffy nose and obstruction, nasosinusitis and watery nasal discharge, the menthol is used as an irritant in medicine and acts on skin or mucous membrane to achieve the effects of cooling and relieving itching, the magnolia flower can treat acute and chronic rhinitis, allergic rhinitis, hypertrophic rhinitis, nasosinusitis, paranasal sinusitis and the like, and the centipeda minima has the advantages of outstanding curative effect, high cure rate, simplicity, low cost and easiness in clinical popularization by matching with other medicinal auxiliary materials.
Example 2:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 7 parts of centipeda minima, 4 parts of eucalyptus leaf extract, 3 parts of bay leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of wrinkled gianthyssop herb and 2 parts of isotonic regulator.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
According to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better.
Example 3:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 4 parts of eucalyptus leaf extract, 3 parts of laurel leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 10 parts of menthol, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of agastache rugosus and 2 parts of an isoosmotic adjusting agent.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis, and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
According to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better.
Example 4:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 7 parts of centipeda minima, 4 parts of eucalyptus leaf extract, 3 parts of bay leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 10 parts of menthol, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of agastache rugosus and 2 parts of an isoosmotic adjusting agent.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: and (4) sterilizing the solution obtained in the step (4), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
The spray prepared in the above example was tested using the following method: opening the dust cover, slightly lifting the head, extending the spray head into one side of the nostril for spraying for 2 times, and inhaling the nursing liquid into the body by inhaling the nasal cavity simultaneously during spraying so as to swallow the nursing liquid; changing the nostril at the other side, and repeating the above application method.
Group of | Time to onset (average) | Smooth duration (average) |
Example 1 | At once | Half a day |
Example 2 | 3min | 2.2h |
Example 3 | 3.5min | 2.5h |
Example 4 | 5min | 30min |
In addition, the comparison and the content show that the special preparation process adopted by the invention (wherein the electrode induction treatment is taken as a core technical point, the treatment greatly enhances the molecule selective permeability of the components of the essence with different compositions, so that the components of the essence of the spray are mutually fused and permeated), the components of the essence extracting solution of the spray are easier to permeate into the skin tissues of the nasal cavity, the durability of cleaning and moistening the nasal cavity is improved on the premise that the nasal cavity is cleared of germs of the product, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, the trouble pressure of using the nasal cavity spray by a patient is better relieved, and no side effect is caused.
Claims (5)
1. A nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 6-8 parts of centipeda minima, 3-5 parts of eucalyptus leaf extract, 2-4 parts of bay leaf extract, 3-5 parts of sandalwood extract, 4-6 parts of magnolia flower, 8-12 parts of menthol, 5-7 parts of plant cellulose, 1-3 parts of radix scutellariae, 6-8 parts of radix sophorae flavescentis, 5-7 parts of agastache rugosus and 1-3 parts of isotonic regulator.
2. the nasal cavity care spray according to claim 1, wherein the plant cellulose is prepared by pulping wheat bran and a mineral acid to α -cellulose, partially depolymerizing the cellulose by treatment, removing non-crystalline parts, and purifying.
3. The nasal care spray according to claim 1, characterized in that: the Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
4. A method of preparing a nasal care spray according to claims 1-3, characterized in that: the preparation method comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
5. The nasal care spray according to claim 4, wherein: irradiating the obtained solution with ultraviolet light source to kill microorganisms in the solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010163052.6A CN111214549A (en) | 2020-03-10 | 2020-03-10 | Nasal cavity nursing spray and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010163052.6A CN111214549A (en) | 2020-03-10 | 2020-03-10 | Nasal cavity nursing spray and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111214549A true CN111214549A (en) | 2020-06-02 |
Family
ID=70808648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010163052.6A Pending CN111214549A (en) | 2020-03-10 | 2020-03-10 | Nasal cavity nursing spray and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111214549A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309558A (en) * | 2016-09-20 | 2017-01-11 | 无比滴(广东)药业有限公司 | Nasal spray |
CN108852982A (en) * | 2018-09-28 | 2018-11-23 | 上海百年吴越化妆品有限公司 | A kind of paste cosmetic formulations and preparation method thereof |
CN109394837A (en) * | 2018-10-22 | 2019-03-01 | 吉林省七维生物科技有限公司 | A kind of nasal mist and preparation method thereof |
CN109431942A (en) * | 2018-12-22 | 2019-03-08 | 上海百年吴越化妆品有限公司 | A kind of acne-eliminating cosmetic Chinese medicine composition and preparation method thereof |
CN109481429A (en) * | 2019-01-22 | 2019-03-19 | 广州蓓思语生物科技有限公司 | A kind of nasal nursing spray |
-
2020
- 2020-03-10 CN CN202010163052.6A patent/CN111214549A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309558A (en) * | 2016-09-20 | 2017-01-11 | 无比滴(广东)药业有限公司 | Nasal spray |
CN108852982A (en) * | 2018-09-28 | 2018-11-23 | 上海百年吴越化妆品有限公司 | A kind of paste cosmetic formulations and preparation method thereof |
CN109394837A (en) * | 2018-10-22 | 2019-03-01 | 吉林省七维生物科技有限公司 | A kind of nasal mist and preparation method thereof |
CN109431942A (en) * | 2018-12-22 | 2019-03-08 | 上海百年吴越化妆品有限公司 | A kind of acne-eliminating cosmetic Chinese medicine composition and preparation method thereof |
CN109481429A (en) * | 2019-01-22 | 2019-03-19 | 广州蓓思语生物科技有限公司 | A kind of nasal nursing spray |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108272862B (en) | Pudilan oral spray and preparation method thereof | |
CN105663243A (en) | Traditional Chinese medicinal composition for treating rhinitis and/or nasosinusitis and drug of traditional Chinese medicinal composition | |
CN105232781A (en) | Spray for removing bad breath, and preparation method thereof | |
CN103301254B (en) | Antibacterial liquid used for nasopharyal meatus and preparation method thereof | |
CN112316017A (en) | Gynecological antibacterial gel and preparation method thereof | |
CN113694024B (en) | Physiological seawater nasal cavity sprayer | |
CN104258455B (en) | A kind of medical bio antiseptic dressing and preparation method thereof | |
CN101129741A (en) | Liquid for clearing heat and promoting eruption | |
CN110151915B (en) | Propolis oral care solution and preparation method thereof | |
CN106309746A (en) | Traditional Chinese medicine composition, preparation method thereof and oral health product | |
KR100735541B1 (en) | A composition for cleaning nasal cavity and a method for preparing the same | |
CN111214549A (en) | Nasal cavity nursing spray and preparation method thereof | |
CN107913234B (en) | Pilose antler grass toothpaste and preparation method thereof | |
US20220193174A1 (en) | Nasal spray for preventing influenza based on red pepper extract and heparin and preparation method thereof | |
CN108743497A (en) | A kind of antibacterial mouthwash of plant source and preparation method thereof | |
CN112121116A (en) | Natural plant active factor antibacterial atomizing agent and preparation method thereof | |
CN1923242A (en) | Medicine for treating nasal cavity disease and preparation thereof | |
CN110604759A (en) | Rhinitis spray and preparation method thereof | |
CN111388571A (en) | Compound essential oil for treating rhinitis and cold | |
CN111407807A (en) | Pharmaceutical composition for treating vasomotor rhinitis and preparation method thereof | |
CN110946816A (en) | Natural herbal ulcer-removing oral and oral cavity spray | |
CN1197595C (en) | Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing | |
CN115554385B (en) | Sheep-loosening herbal liquid | |
CN113633717B (en) | Electronic atomized liquid composition for nasal cavity care, application thereof and obtained care product | |
CN107320652A (en) | A kind of medicine spray for treating tinea pedis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200602 |